Paliperidone Powder CAS 144598-75-4 Antipsychotic Paliperidone API Paliperidone

• Customization: Available
• Powder: Yes
• Customized: Customized
• Certification: GMP, ISO 9001, USP, BP
• Suitable for: Adult
• State: Powder
• Purity: >98%
• Sample: Available
• OEM: Available
• MOQ: 1kg
• Keyword 1: Paliperidone
• Keyword 2: Paliperidone Powder
• Storage: Dry and Cool Place
• Transport Package: Foil Bag/25kg Drum
• Specification: 98%
• Trademark: /
• Origin: China
• Production Capacity: 10000

Product Description

Description 
Paliperidone, (±)-3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-9-hydroxy-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one(Invega), is essentially insoluble in water and is available asextended-release tablets. Paliperidone is delivered at a constantrate using an osmotic drug release device (OsmoticRelease Oral Systems [OROS]). Paliperidone is FDA-approved for schizophrenia aged 12-17. However, the pharmacologic portfolio, extrapolation from adult studies, and the long track record of the parent drug, risperidone in child/adolescent psychiatric (CAP) population might expand its therapeutic potential

Name	Paliperidone
Grade	Pharmaceutical Grade
Appearance	white powder
Specification	98%

Function and Application
Schizophrenia: Paliperidone is prescribed for the treatment of schizophrenia, including its acute and maintenance phases.
Bipolar Disorder: It is also used to manage manic or mixed episodes associated with bipolar I disorder.
Adjunctive Therapy: In some cases, paliperidone may be used as an adjunctive therapy to mood stabilizers for the treatment of bipolar disorder.